Chinese government confirms GSK bribery probe
This article was originally published in Scrip
China's Ministry of Public Security has issued a statement providing official confirmation that an investigation of some executives at GlaxoSmithKline's operations in the country is underway, on suspicion of their involvement in what it terms "serious economic crimes".
You may also be interested in...
While it has raised the full-year profit outlook, Takeda came in under analysts' consensus for some of its fiscal first-half figures, pointing to a growing forex impact.
Product review report reveals multiple delays and missteps on route to market, holding valuable lessons for other gene therapy developers but also evidencing an ultimately welcoming environment.
Join us for a quick audio roundup of major developments in the international biopharma industry over the past week, as covered by Scrip's global team.